Cena s DPH / bez DPH
Hlavní stránka>BS EN 16939:2017 Animal feeding stuffs. Methods of sampling and analysis. Detection of tylosin, spiramycin and virginiamycin. Thin Layer Chromatography and bioautography
sklademVydáno: 2017-09-01
BS EN 16939:2017 Animal feeding stuffs. Methods of sampling and analysis. Detection of tylosin, spiramycin and virginiamycin. Thin Layer Chromatography and bioautography

BS EN 16939:2017

Animal feeding stuffs. Methods of sampling and analysis. Detection of tylosin, spiramycin and virginiamycin. Thin Layer Chromatography and bioautography

Formát
Dostupnost
Cena a měna
Anglicky Zabezpečené PDF
K okamžitému stažení
6240 Kč
Anglicky Tisk
Skladem
6240 Kč
Označení normy:BS EN 16939:2017
Počet stran:30
Vydáno:2017-09-01
ISBN:978 0 580 91797 4
Status:Standard
Popis

BS EN 16939:2017


This standard BS EN 16939:2017 Animal feeding stuffs. Methods of sampling and analysis. Detection of tylosin, spiramycin and virginiamycin. Thin Layer Chromatography and bioautography is classified in these ICS categories:
  • 71.040.50 Physicochemical methods of analysis
  • 65.120 Animal feeding stuffs
The method makes it possible to detect and identify spiramycin, tylosin and virginiamycin in animal feeding stuffs (feed raw materials of mainly plant origin and compound feeds) excluding mineral feeds and premixtures. The limit of detection is about 2 mg/kg for spiramycin, 1 mg/kg for tylosin and 1 mg/kg for virginiamycin. In some milk replacers, it can be slightly higher than 1 mg/kg for virginiamycin. Reported limits of detection are probably little overestimated but were fully validated during the collaborative study (see Annex B). In each laboratory, each day of analysis, spiked blank samples at 1 mg/kg for spiramycin and virginiamycin and at 0,5 mg/kg for tylosin are analysed for checking lower detection limits (see 9.2 and 9.3). These lower limits of detection are achievable, but should be established with an in-house validation first. Some other antibiotics can interfere in the detection of these 3 specific macrolide antibiotics. The known interferences are specified in Annex A of the method. That method should be used as a qualitative screening and/or a post-screening method (after microbiological plate test, for example). The follow-up of the antibiotics presence may be done by other analytical technics (LC and/or LC-MS technics) ([4], [10]). For confirmatory purposes, LCMS is required.